Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-Kilobase genomic stuffer

Journal of Virology

Volumn 75, Issue 20, 2001, Pages 9896-9908

  Hillgenberg, M ^a   Tonnies H ^a   Strauss, M ^a  

^a DeveloGen AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE SEQUENCE; GENE TRANSFER; GENETIC TRANSDUCTION; GENOME; HUMAN; HUMAN CELL; MARKER GENE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TRANSGENE; VIRUS DNA CELL DNA INTERACTION; X CHROMOSOME;

ADENOVIRUSES, HUMAN; CELL LINE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELPER VIRUSES; HUMANS; VIRUS INTEGRATION; X CHROMOSOME;

EID: 0034812283     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.20.9896-9908.2001     Document Type: Article

References (76)

1. Complementation of helper-dependent adenoviral vectors: Size effects and titer fluctuations
2. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
3. Adenovirus vectors for gene delivery
4. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3
5. Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase
6. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection
7. Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium
8. Persistence in muscle of an adenoviral vector that lacks all viral genes
9. DNA from both high-capacity and first-generation adenoviral vectors remain intact in skeletal muscle
10. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase
11. Cellular and humoral responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long term expression
12. A role for DNA-PK in retroviral DNA integration
13. Alu repeats and human disease
14. Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus
15. Uptake, fixation, and expression of foreign DNA in mammalian cells: The organization of integrated adenovirus DNA sequences
16. The integration of foreign DNA into mammalian genomes and its consequences: A concept for oncogenesis
17. A new concept in (adenoviral) oncogenesis: Integration of foreign DNA and its consequences
18. Ku, a DNA repair protein with multiple cellular functions?
19. The mechanism of adenoviral DNA integration: Studies in a cell-free system
20. Recombinant adenovirus deleted for all viral genes for gene therapy of cystic fibrosis
21. Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF)
22. Gene targeting with a replication-defective adenovirus vector
23. Patch homologies and the integration of adenovirus DNA in mammalian cells
24. Characteristics of a human cell line transformed by DNA from a human adenovirus type 5
25. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes
26. Construction of adenovirus vectors through Cre/lox-recombination
27. Frequency and stability of chromosomal integration of adenovirus vectors
28. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence
29. System for efficient helper-dependent minimal adenovirus construction and rescue
30. A simple and efficient method for purification of infectious recombinant adenovirus
31. Stable gene transfer and tissue-specific expression of a human globin gene using adenoviral vectors
32. Transfer of genes into hematopoietic cells using recombinant DNA viruses
33. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase
34. Mechanisms and therapeutic applications of immune stimulatory CpG DNA
35. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells
36. Gene targeting for gene therapy: Prospects
37. The polypeptides of adenovirus. I. Evidence for multiple components in the virion and a comparison of types 2, 7A, and 12
38. A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5
39. Alu sequences
40. Rescue, propagation and partial purification of a helper-dependent adenovirus vector
41. Gene targeting in mouse embryonic stem cells with an adenoviral vector
42. 1-antitrypsin with negligible toxicity
43. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
44. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene
45. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium
46. Creation and repair of specific DNA double-strand breaks in vivo following infection with adenovirus vectors expressing Saccharomyces cerevisiae HO endonuclease
47. Sensitivity and reproducibility of adenoviral infectious titer determination
48. SINEs and LINEs share common 3′ sequences: A review
49. Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type 1
50. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging
51. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors
52. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
53. Fluorescence in situ hybridization with human chromosome-specific libraries: Detection of trisomy 21 and translocations of chromosome 4
54. Long term culture of normal and neoplastic human glia
55. Covalently closed circles of adenovirus 5 DNA
56. Optimization of the helper-dependent adenovirus system for production and potency in vivo
57. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxixity
58. An in vivo assay for measuring the recombination potential between DNA sequences in mammalian cells
59. Widespread long-term gene transfer to mouse skeletal muscles and heart
60. High-fidelity gene targeting in embryonic stem cells by using sequence replacement vectors
61. Transgenesis by adenovirus-mediated gene transfer into zona-free eggs
62. Infection of eucaryotic cells by helper-independent recombinant adenoviruses: Early region 1 is not obligatory for integration of viral DNA
63. Nucleotide sequence analysis of the linked left and right hand terminal regions of adenovirus type 5 DNA present in the transformed rat cell line 5RK20
64. Arrangement of integrated viral DNA sequences in cells transformed by adenovirus types 2 and 5
65. Viral DNA sequences in adenovirus transformed cells
66. Correction of a deletion mutant by gene targeting with an adenoviral vector
67. Human repeat-mediated integration of selectable markers into somatic cell hybrids
68. Deletion of the E4 region of the genome produces adenovirus DNA concatemers
69. Nonviral retroposons: Genes, pseudogenes, and transposable elements generated by the reverse flow of genetic information
70. Therapeutic gene targeting
71. MHC class I restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1 deleted recombinant adenoviruses
72. Cellular immunity to viral antigens limits E1-deleted recombinant adenoviruses for gene therapy
73. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
74. Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse
75. High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation
76. Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A